Ropinirole (HCl)

Ropinirole (HCl) is a dopamine receptor agonist, used for the treatment of Parkinson`s disease. Ropinirole (HCl) is also used with levodopa in more advanced disease. It may also be used for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS) in adults,


Adult Dose
Dose: 0.25 mg
Single Dose: 0.25 (0.25)
Frequency: 8 hourly
Route: PO
Instructions: Initial dose for 1st week.
Neonatal
Paedriatic
Characteristics
Ropinirole is the derivative of Ropinirole (HCl). It is of Synthetic origin. . The Molecular Weight of Ropinirole (HCl) is 296.80. Its pKa is 9.5.
Contraindications
Ropinirole (HCl) is contraindicated in conditions like Hypersensitivity,Pregnancy,Lactation.
Effects
The severe or irreversible adverse effects of Ropinirole (HCl), which give rise to further complications include Hallucinations, Cardiac arrhythmias, Confusion, Anxiety, Psychosis, Depression, Postural hypotension, Amnesia.The signs and symptoms that are produced after the acute overdosage of Ropinirole (HCl) include Nausea, Vomiting, Confusion, Dizziness, Agitation, Orthostatic hypotension, Chest pain, Dystonia.The symptomatic adverse reactions produced by Ropinirole (HCl) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Nausea, Vomiting, Abdominal pain, Confusion, Leg edema.
Indications
Ropinirole (HCl) is primarily indicated in conditions like Idiopathic parkinsons disease.
Interactions
No data regarding the interactions of Ropinirole (HCl) was found.
Interfrence
Risks
Drug should not be given to Paediatrics, Pregnant Mothers, patients suffering from Kidney dysfunction, patients suffering from Liver Malfunction, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
Tab Store Below 25°C. Protect from Sunlight and Moisture.
Warnings
Ropinirole should be used with caution in patients with mild to moderate hepatic impairment and renal impairment (avoid in severe); severe cardiovascular disease; major psychotic disorders; avoid abrupt withdrawl.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.